Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study

Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study

Purpose: To determine the beneficiaries of capecitabine in patients with triple-negative breast cancer (TNBC) who failed to achieve pathological complete response (pCR) by analyzing the efficacy of the drug in different HER2 statuses and TNM stages. Methods: The Kaplan–Meier survival curve was plott...

Full description

Saved in:
Bibliographic Details
Main Authors: Youzhao Ma, Mingda Zhu, Jingyang Zhang, Dechuang Jiao, Yangyang Hou, Xiuchun Chen, Zhenzhen Liu
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Breast
Subjects:
Capecitabine
Triple-negative breast cancer
Neoadjuvant therapy
HER2-Low
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625004941
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items